Hubert L. Allen, EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES (ABT), sold 314,842 shares at $118.81 ($36.8M) on 2024-10-21, disclosed to the SEC on 2024-10-23.
Scheduled sale ($36.8M) by EXECUTIVE VICE PRESIDENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.98 | 150,271 | $17.6M | 47.7% |
| 2 | $116.98 | 150,271 | $17.6M | 47.7% |
| 3 | $118.15 | 5,901 | $697K | 1.9% |
| 4 | $118.15 | 5,901 | $697K | 1.9% |
| 5 | $118.81 | 1,249 | $148K | 0.4% |
| 6 | $118.81 | 1,249 |
| $148K |
| 0.4% |
| Total | $117.04 avg | 314,842 | $36.8M | 100% |
| Filing → |
| ABT | SELL | 2023-03-02 | $215K | — | Filing → |
| ABT | SELL | 2022-03-02 | $343K | — | Filing → |
| ABT | SELL | 2021-02-03 | $50.2M | — | Filing → |